6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
4m ago	Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors
4m ago	NN to Receive Long-Awaited CARES Act IRS Refund
19m ago	Ideal Power to Host First Quarter 2026 Results Conference Call on May 14, 2026 at 10:00 AM Eastern Time
20m ago	OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026
21m ago	Euroseas Ltd. Announces Expansion of its Feeder Containership Newbuilding Program Ordering Two 2,800 teu High-Reefer Vessels and Two 1,800 teu Vessels

About

Dogwood Therapeutics, Inc. (NASDAQ:DWTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M

Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy

Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development

Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026

Financials

Revenue

$0

Market Cap

$67.26 M

EPS

-7.13

Community Chat

Ask AI